on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Disclosure on Spire Healthcare
The Vanguard Group, Inc. has released Form 8.3 related to its interests in Spire Healthcare Group plc. As of February 20, 2026, Vanguard holds 14,509,826 shares, representing a 3.60% stake in Spire Healthcare's 1p ordinary shares. This information is disclosed as per Rule 8.3 of the Takeover Code.
The disclosure notes a recent sale of 6,425 ordinary shares at a price of 2.00 GBP per share. No cash-settled or stock-settled derivatives were reported in this disclosure, and there are no current indemnity or dealing arrangements in place.
Vanguard states that there are no agreements or understandings regarding voting rights or future transactions involving Spire Healthcare securities. No Supplemental Form 8 has been attached, indicating no open stock-settled derivatives or agreements exist.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news